Target intelligence / Profile preview

Festuca pratensis allergen 13 (Fes p 13)

Target
Fes p 13
Molecular classification
Enzyme, Polygalacturonase, Group 13 grass allergen
01

Overview

Fes p 13 is a protein allergen found in the pollen of Festuca pratensis, commonly known as meadow fescue, a perennial grass species widely distributed in temperate regions [2, 16]. It is classified as a Group 13 grass allergen and functions biochemically as a polygalacturonase, an enzyme that hydrolyzes alpha-1,4-D-galactosiduronic linkages in pectin to facilitate pollen tube growth and germination [2, 3]. In individuals sensitized to grass pollen, inhalation of Fes p 13 triggers Type I hypersensitivity reactions, leading to clinical symptoms such as allergic rhinitis, conjunctivitis, and asthma [2, 18]. While often considered a minor allergen compared to Groups 1 and 5, it is a significant component for the diagnosis and treatment of pollinosis [3, 16]. Fes p 13 is a target for allergen-specific immunotherapy (AIT), where controlled exposure to the allergen aims to desensitize the immune system and provide long-term relief from allergic symptoms [2, 17].

Other names
Meadow fescue allergen 13Polygalacturonase Fes p 13Fes p 13.0101
02

Mechanism of action

Allergen-specific immunotherapy (AIT) induces immunological tolerance by shifting the immune response from a Th2-dominated profile to a Th1/Treg profile, increasing the production of regulatory cytokines like IL-10 and allergen-specific IgG4 antibodies that block IgE-mediated mast cell activation [2, 4, 18].

03

Biological functions

Pectin degradationCarbohydrate metabolismPollen germinationPollen tube growth
04

Disease associations

Allergic rhinitisAllergic conjunctivitisAsthmaPollinosis
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsOral pruritus
06

Interacting drugs

Meadow fescue pollen extract

2 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Fes p 13Specific IgG4 (sIgG4) to Fes p 13Skin prick test (SPT) reactivity

Beyond the preview

Go deeper on Festuca pratensis allergen 13 (Fes p 13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Festuca pratensis allergen 13 (Fes p 13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call